​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $91.17, with a high of $120.00 and a low of $60.00. This represents a 59.53% increase from the last price of $57.15.

$35 $52 $69 $86 $103 $120 High: $120 Avg: $91.17 Low: $60 Last Closed Price: $57.15

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 43 Wall Street analysts. The breakdown includes 1 Strong Buy (2.33%), 39 Buy (90.70%), 3 Hold (6.98%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 43 3 39 1 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific59.53%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks33.64%

Price Target Trends

1M3M12M
# Anlaysts121652
Avg Price Target$82.58$84.31$106.88
Last Closing Price$57.15$57.15$57.15
Upside/Downside44.50%47.52%87.02%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 269222--33
Apr, 261024---34
Mar, 26925---34
Feb, 267261--34
Jan, 267252--34
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 19, 2026Robert W. Baird$75.00$55.9234.12%31.23%
Apr 29, 2026Daiwa$60.00$58.452.65%4.99%
Apr 23, 2026RBC Capital$100.00$65.8051.98%74.98%
Apr 23, 2026Oppenheimer$90.00$65.7236.94%57.48%
Apr 23, 2026William PlovanicCanaccord Genuity$71.00$64.879.45%24.23%
Apr 23, 2026Mike MatsonNeedham$77.00$64.8718.70%34.73%
Apr 23, 2026Truist Financial$85.00$64.8731.03%48.73%
Apr 23, 2026Robert W. Baird$78.00$64.8720.24%36.48%
Apr 23, 2026Wells Fargo$75.00$64.8715.62%31.23%
Apr 23, 2026Matt MiksicBarclays$96.00$64.8747.99%67.98%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 29, 2026DaiwaNeutraldowngrade
Apr 23, 2026NeedhamBuyBuyhold
Apr 23, 2026BarclaysOverweightOverweighthold
Apr 22, 2026Goldman SachsBuyBuyhold
Apr 22, 2026JefferiesBuyBuyhold
Apr 22, 2026BTIGBuyBuyhold
Mar 24, 2026Evercore ISIOutperformOutperformhold
Mar 16, 2026JefferiesBuyBuyhold
Feb 06, 2026BernsteinOutperformOutperformhold
Feb 05, 2026RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.69$0.45$1.08$1.26$1.96---
Avg Forecast$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-57.14%-73.99%-46.27%-48.99%-30.25%---

Revenue Forecast

$10B $14B $18B $22B $26B $30B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.89B$12.68B$14.24B$16.75B$20.07B---
Avg Forecast$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %0.12%-0.02%0.88%0.83%6.83%---

Net Income Forecast

$500M $2B $3B $4B $6B $7B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04B$698.00M$1.59B$1.85B$2.89B---
Avg Forecast$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %9.79%-23.22%1.46%-48.62%-29.84%---

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 43 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 39 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 43 Wall Street analysts, averages $91.17 over the next 12 months. The price target range spans from $60 at the low end to $120 at the high end, suggesting a potential 59.53% change from the previous closing price of $57.15.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 59.53% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (33.64%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • May 2026: 27.27% Strong Buy, 66.67% Buy, 6.06% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 29.41% Strong Buy, 70.59% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 26.47% Strong Buy, 73.53% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2026 is $3.2, marking a 63.27% increase from the reported $1.96 in 2025. Estimates for the following years are $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2026 is $20.7B, reflecting a 3.10% increase from the reported $20.07B in 2025. The forecast for 2027 is $22.61B, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2026 stands at $4.68B, representing an 62.16% increase from the reported $2.89B in 2025. Projections indicate $3.93B in 2027, and $5.8B in 2028.